These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36252997)

  • 1. Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.
    Zhang Q; Xiu B; Zhang L; Chen M; Chi W; Li L; Guo R; Xue J; Yang B; Huang X; Shao ZM; Huang S; Chi Y; Wu J
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36252997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-dependent Turnover of Adenosine Deaminase Acting on RNA 1 (ADAR1) Is Required for Efficient Antiviral Activity of Type I Interferon.
    Li L; Qian G; Zuo Y; Yuan Y; Cheng Q; Guo T; Liu J; Liu C; Zhang L; Zheng H
    J Biol Chem; 2016 Nov; 291(48):24974-24985. PubMed ID: 27729454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer.
    Gomez S; Cox OL; Walker RR; Rentia U; Hadley M; Arthofer E; Diab N; Grundy EE; Kanholm T; McDonald JI; Kobyra J; Palmer E; Noonepalle S; Villagra A; Leitenberg D; Bollard CM; Saunthararajah Y; Chiappinelli KB
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
    Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
    Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.
    Liao GR; Tseng YY; Tseng CY; Lin FY; Yamada Y; Liu HP; Kuan CY; Hsu WL
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade.
    Ishizuka JJ; Manguso RT; Cheruiyot CK; Bi K; Panda A; Iracheta-Vellve A; Miller BC; Du PP; Yates KB; Dubrot J; Buchumenski I; Comstock DE; Brown FD; Ayer A; Kohnle IC; Pope HW; Zimmer MD; Sen DR; Lane-Reticker SK; Robitschek EJ; Griffin GK; Collins NB; Long AH; Doench JG; Kozono D; Levanon EY; Haining WN
    Nature; 2019 Jan; 565(7737):43-48. PubMed ID: 30559380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis.
    Liddicoat BJ; Hartner JC; Piskol R; Ramaswami G; Chalk AM; Kingsley PD; Sankaran VG; Wall M; Purton LE; Seeburg PH; Palis J; Orkin SH; Lu J; Li JB; Walkley CR
    Exp Hematol; 2016 Oct; 44(10):947-63. PubMed ID: 27373493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive editing of cellular and viral double-stranded RNA structures accounts for innate immunity suppression and the proviral activity of ADAR1p150.
    Pfaller CK; Donohue RC; Nersisyan S; Brodsky L; Cattaneo R
    PLoS Biol; 2018 Nov; 16(11):e2006577. PubMed ID: 30496178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis.
    Vlachogiannis NI; Tual-Chalot S; Zormpas E; Bonini F; Ntouros PA; Pappa M; Bournia VK; Tektonidou MG; Souliotis VL; Mavragani CP; Stamatelopoulos K; Gatsiou A; Sfikakis PP; Stellos K
    J Autoimmun; 2021 Dec; 125():102755. PubMed ID: 34857436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of RNA editing enzyme ADAR1 in human disease.
    Song B; Shiromoto Y; Minakuchi M; Nishikura K
    Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1665. PubMed ID: 34105255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS.
    Raghava Kurup R; Oakes EK; Manning AC; Mukherjee P; Vadlamani P; Hundley HA
    J Biol Chem; 2022 Sep; 298(9):102267. PubMed ID: 35850307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease.
    Vlachogiannis NI; Sachse M; Georgiopoulos G; Zormpas E; Bampatsias D; Delialis D; Bonini F; Galyfos G; Sigala F; Stamatelopoulos K; Gatsiou A; Stellos K
    J Mol Cell Cardiol; 2021 Nov; 160():111-120. PubMed ID: 34302813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-mediated viral RNA editing in hepatocytes.
    Wang L; Sun Y; Song X; Wang Z; Zhang Y; Zhao Y; Peng X; Zhang X; Li C; Gao C; Li N; Gao L; Liang X; Wu Z; Ma C
    Cell Mol Immunol; 2021 Aug; 18(8):1871-1882. PubMed ID: 34253859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
    Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
    Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-Editing Enzyme ADAR1 p150 Isoform Is Critical for Germinal Center B Cell Response.
    Li Y; Ruan GX; Chen W; Huang H; Zhang R; Wang J; Li Y; Xu S; Ou X
    J Immunol; 2022 Sep; 209(6):1071-1082. PubMed ID: 35977796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
    Nakahama T; Kawahara Y
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
    Guo X; Wiley CA; Steinman RA; Sheng Y; Ji B; Wang J; Zhang L; Wang T; Zenatai M; Billiar TR; Wang Q
    J Neuroinflammation; 2021 Jul; 18(1):169. PubMed ID: 34332594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
    Liu Y; Wolff KC; Jacobs BL; Samuel CE
    Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment.
    Lin W; Luo Y; Wu J; Zhang H; Jin G; Guo C; Zhou H; Liang H; Xu X
    J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37935565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAR1, inosine and the immune sensing system: distinguishing self from non-self.
    Liddicoat BJ; Chalk AM; Walkley CR
    Wiley Interdiscip Rev RNA; 2016; 7(2):157-72. PubMed ID: 26692549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.